Clinical Trial Update: A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC (Phase 1) [Phase 1]

View source ↗

Summary

Clinical trial update reporting the completion of the Phase 1/2 safety and immunogenicity trial of the COVID-19 vaccine COVIVAC, with results posted on 2025-02-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syndrome
• Viral Pneumonia

Drugs mentioned

• COVIVAC

Snippet

Sponsor: Institute of Vaccines and Medical Biologicals, Vietnam | Conditions: COVID-19 Disease, SARS Pneumonia | Phase 1 | Status: COMPLETED | Results posted: 2025-02-13